Amulet Pharmaceuticals

Amulet Pharmaceuticals discovers and develops novel therapeutics to address known liabilities of current therapies serving unmet markets.

Amulet Pharmaceuticals discovers and develops novel therapeutics using their NORTECHâ„¢ technology to address known liabilities of current therapies serving large unmet markets. Their lead program (AMU-301) treats diabetic gastroparesis an unmet complication of diabetes affecting over 3 million women in the United States.